CD274 and cancer: For instance, surface proteins expressed by cancer cells, such as PD‐L1, that help evade immune surveillance have been targeted with immunotherapeutic agents.[16] However, many more genes that have similar functions may be alternative targets for development of new immunotherapeutic agents with high potency and efficiency.